A Minimal Synthetic Cleavage Module Enables Selective Degradation of Pathogenic r(CUG) Repeats in Cells

A groundbreaking study has demonstrated that a compact synthetic RNA cleavage module, capable of targeting and degrading specific RNA sequences, can be used to selectively degrade pathogenic RNA repeats in cells. This advance could pave the way for novel therapeutic strategies for diseases caused by aberrant RNA repeats.

The researchers engineered a Fe(II)-coordinating warhead, a small molecular component that can be programmed to selectively degrade RNA targets. By coupling this synthetic cleavage module to a small molecule that recognizes expanded r(CUG) repeats, a type of RNA repeat associated with myotonic dystrophy type 1 (DM1), they were able to selectively degrade the pathogenic RNA while leaving wild-type and transcripts with short r(CUG) repeats unharmed.

The team tested their approach in DM1 patient-derived myoblasts, a type of cell commonly used in disease modeling. They found that degradation of the mutant repeat RNA resulted in a significant reduction of DM1-associated pathology, including the formation of nuclear foci, sequestration of the MBNL1 protein, and aberrant pre-mRNA splicing. Importantly, the synthetic cleavage module did not cause any DNA damage, making it a potentially safer alternative to existing therapies.

This study represents a major step forward in the development of RNA-targeting therapies, as it demonstrates that minimal synthetic cleavage modules can effectively replace complex natural product warheads to selectively degrade disease-causing RNAs in cells. The researchers believe that this approach could be extended to other RNA-targeting diseases, offering new hope for patients with debilitating hereditary disorders.